HomeMy WebLinkAboutExhibiter DEPARTMENT OF HEALTH & HUMAN SERVICES
Acceptance of Terms and Conditions
If you receive a payment from funds appropriated in the Public Health and Social Services
Emergency Fund for provider relief ("Relief Fund") under Public Law 116-136 and retain that
payment for at least 30 days without contacting HHS regarding remittance of those funds, you
are deemed to have accepted the following Terms and Conditions. Please also indicate your
acceptance below. This is not an exhaustive list and you must comply with any other relevant
statutes and regulations, as applicable.
Your commitment to full compliance with all Terms and Conditions is material to the Secretary's
decision to disburse these funds to you. Non-compliance with any Term or Condition is grounds
for the Secretary to recoup some or all of the payment made from the Relief Fund.
These Terms and Conditions apply directly to the recipient of payment from the Relief Fund. In
general, the requirements that apply to the recipient also apply to subrecipients and contractors,
unless an exception is specified.
Relief Fund Payment from Initial $30 Billion General Distribution Terms and Conditions
• The "Payment" means the funds received from the Public Health and Social Services
Emergency Fund ("Relief Fund"). The Recipient means the healthcare provider, whether
an individual or an entity, receiving the Payment.
• The Recipient certifies that it billed Medicare in 2019; provides or provided after January
31, 2020 diagnoses, testing, or care for individuals with possible or actual cases of
COVID-19; is not currently terminated from participation in Medicare or precluded from
receiving payment through Medicare Advantage or Part D; is not currently excluded from
participation in Medicare, Medicaid, and other Federal health care programs; and does
not currently have Medicare billing privileges revoked.
• The Recipient certifies that the Payment will only be used to prevent, prepare for, and
respond to coronavirus, and that the Payment shall reimburse the Recipient only for
health care related expenses or lost revenues that are attributable to coronavirus.
• The Recipient certifies that it will not use the Payment to reimburse expenses or losses
that have been reimbursed from other sources or that other sources are obligated to
reimburse.
• The Recipient shall submit reports as the Secretary determines are needed to ensure
compliance with conditions that are imposed on this Payment, and such reports shall be
in such form, with such content, as specified by the Secretary in future program
instructions directed to all Recipients.
er DEPARTMENT OF HEALTH & HUMAN SERVICES
• The Recipient certifies that all information it provides as part of its application for the
Payment, as well as all information and reports relating to the Payment that it provides in
the future at the request of the Secretary or Inspector General, are true, accurate and
complete, to the best of its knowledge. The Recipient acknowledges that any deliberate
omission, misrepresentation, or falsification of any information contained in this Payment
application or future reports may be punishable by criminal, civil, or administrative
penalties, including but not limited to revocation of Medicare billing privileges, exclusion
from federal health care programs, and/or the imposition of fines, civil damages, and/or
imprisonment.
• Not later than 10 days after the end of each calendar quarter, any Recipient that is an
entity receiving more than $150,000 total in funds under the Coronavirus Aid, Relief, and
Economics Security Act (P.L. 116-136), the Coronavirus Preparedness and Response
Supplemental Appropriations Act (P.L. 116-123), the Families First Coronavirus
Response Act (P.L. 116-127), or any other Act primarily making appropriations for the
coronavirus response and related activities, shall submit to the Secretary and the
Pandemic Response Accountability Committee a report. This report shall contain: the
total amount of funds received from HHS under one of the foregoing enumerated Acts;
the amount of funds received that were expended or obligated for reach project or
activity; a detailed list of all projects or activities for which large covered funds were
expended or obligated, including: the name and description of the project or activity, and
the estimated number of jobs created or retained by the project or activity, where
applicable; and detailed information on any level of sub -contracts or subgrants awarded
by the covered recipient or its subcontractors or subgrantees, to include the data elements
required to comply with the Federal Funding Accountability and Transparency Act of
2006 allowing aggregate reporting on awards below $50,000 or to individuals, as
prescribed by the Director of the Office of Management and Budget.
• The Recipient shall maintain appropriate records and cost documentation including, as
applicable, documentation described in 45 CFR § 75.302 — Financial management and 45
CFR § 75.361 through 75.365 — Record Retention and Access, and other information
required by future program instructions to substantiate the reimbursement of costs under
this award. The Recipient shall promptly submit copies of such records and cost
documentation upon the request of the Secretary, and Recipient agrees to fully cooperate
in all audits the Secretary, Inspector General, or Pandemic Response Accountability
Committee conducts to ensure compliance with these Terms and Conditions.
• The Secretary has concluded that the COVID-19 public health emergency has caused
many healthcare providers to have capacity constraints. As a result, patients that would
ordinarily be able to choose to receive all care from in -network healthcare providers may
no longer be able to receive such care in -network. Accordingly, for all care for a
presumptive or actual case of COVID-19, Recipient certifies that it will not seek to
collect from the patient out-of-pocket expenses in an amount greater than what the patient
would have otherwise been required to pay if the care had been provided by an in -
network Recipient.
er DEPARTMENT OF HEALTH & HUMAN SERVICES
The following statutory provisions also apply:
General Provisions in FY 2020 Consolidated Appropriation
SEC. 202. Executive Pay. None of the funds appropriated in this title shall be used to pay the
salary of an individual, through a grant or other extramural mechanism, at a rate in excess of
Executive Level II:
SEC. 210. Funding Prohibition for Gun Control Advocacy. None of the funds made available
in this title may be used, in whole or in part, to advocate or promote gun control.
SEC. 503. Lobbying
(a) No part of any appropriation contained in this Act or transferred pursuant to section 4002 of
Public Law 111-148 shall be used, other than for normal and recognized executive -legislative
relationships, for publicity or propaganda purposes, for the preparation, distribution, or use of
any kit, pamphlet, booklet, publication, electronic communication, radio, television, or video
presentation designed to support or defeat the enactment of legislation before the Congress or
any State or local legislature or legislative body, except in presentation to the Congress or any
State or local legislature itself, or designed to support or defeat any proposed or pending
regulation, administrative action, or order issued by the executive branch of any State or local
government, except in presentation to the executive branch of any State or local government
itself.
(b) No part of any appropriation contained in this Act or transferred pursuant to section 4002 of
Public Law 111-148 shall be used to pay the salary or expenses of any grant or contract
recipient, or agent acting for such recipient, related to any activity designed to influence the
enactment of legislation, appropriations, regulation, administrative action, or Executive order
proposed or pending before the Congress or any State government, State legislature or local
legislature or legislative body, other than for normal and recognized executive -legislative
relationships or participation by an agency or officer of a State, local or tribal government in
policymaking and administrative processes within the executive branch of that government.
(c) The prohibitions in subsections (a) and (b) shall include any activity to advocate or promote
any proposed, pending or future Federal, State or local tax increase, or any proposed, pending,
or future requirement or restriction on any legal consumer product, including its sale or
marketing, including but not limited to the advocacy or promotion of gun control.
SEC. 506. Prohibits Use of Federal Funds for Abortions.
er DEPARTMENT OF HEALTH & HUMAN SERVICES
(a) None of the funds appropriated in this Act, and none of the funds in any trust fund to which
funds are appropriated in this Act, shall be expended for any abortion.
(b) None of the funds appropriated in this Act, and none of the funds in any trust fund to which
funds are appropriated in this Act, shall be expended for health benefits coverage that includes
coverage of abortion.
(c) The term "health benefits coverage" means the package of services covered by a managed
care provider or organization pursuant to a contract or other arrangement.
SEC. 507 Limitations on Abortion Funding Prohibition
(a) The limitations established in the preceding section shall not apply to an abortion—
(1) if the pregnancy is the result of an act of rape or incest; or
(2) in the case where a woman suffers from a physical disorder, physical injury, or physical
illness, including a life -endangering physical condition caused by or arising from the pregnancy
itself, that would, as certified by a physician, place the woman in danger of death unless an
abortion is performed.
(b) Nothing in the preceding section shall be construed as prohibiting the expenditure by a State,
locality, entity, or private person of State, local, or private funds (other than a State's or locality's
contribution of Medicaid matching funds).
(c) Nothing in the preceding section shall be construed as restricting the ability of any managed
care provider from offering abortion coverage or the ability of a State or locality to contract
separately with such a provider for such coverage with State funds (other than a State's or
locality's contribution of Medicaid matching funds).
(d)(1) None of the funds made available in this Act may be made available to a Federal agency
or program, or to a State or local government, if such agency, program, or government subjects
any institutional or individual health care entity to discrimination on the basis that the health care
entity does not provide, pay for, provide coverage of, or refer for abortions.
(2) In this subsection, the term "health care entity" includes an individual physician or other
health care professional, a hospital, a provider -sponsored organization, a health maintenance
organization, a health insurance plan, or any other kind of health care facility, organization, or
plan.
Prohibits Use of Funds for Embryo Research
SEC. 508. Prohibits Use of Funds for Embryo Research
er DEPARTMENT OF HEALTH & HUMAN SERVICES
(a) None of the funds made available in this Act may be used for—
(1) the creation of a human embryo or embryos for research purposes; or
(2) research in which a human embryo or embryos are destroyed, discarded, or knowingly
subjected to risk of injury or death greater than that allowed for research on fetuses in utero
under 45 CFR 46.204(b) and section 498(b) of the Public Health Service Act (42 U.S.C.
289g(b)).
(b) For purposes of this section, the term "human embryo or embryos" includes any organism,
not protected as a human subject under 45 CFR 46 as of the date of the enactment of this Act,
that is derived by fertilization, parthenogenesis, cloning, or any other means from one or more
human gametes or human diploid cells.
SEC. 509. Prohibits Promotion of Legalization of Controlled Substances
(a) None of the funds made available in this Act may be used for any activity that promotes the
legalization of any drug or other substance included in schedule I of the schedules of controlled
substances established by section 202 of the Controlled Substances Act except for normal and
recognized executive -congressional communications.
(b) The limitation in subsection (a) shall not apply when there is significant medical evidence of
a therapeutic advantage to the use of such drug or other substance or that federally sponsored
clinical trials are being conducted to determine therapeutic advantage.
SEC. 515. (b) Prohibits Asking Candidates for Federal Scientific Advisory Committees Their
Political Affiliations; Prohibits Distribution of Intentionally False Information
(b) None of the funds made available in this Act may be used to disseminate information that is
deliberately false or misleading.
SEC. 520. Pornography.
(a) None of the funds made available in this Act may be used to maintain or establish a
computer network unless such network blocks the viewing, downloading, and exchanging of
pornography.
(b) Nothing in subsection (a) shall limit the use of funds necessary for any Federal, State, tribal,
or local law enforcement agency or any other entity carrying out criminal investigations,
prosecution, or adjudication activities.
SEC. 521. Prohibits Funding ACORN or Its Affiliates or Subsidiaries. None of the funds
made available under this or any other Act, or any prior Appropriations Act, may be provided to
er DEPARTMENT OF HEALTH & HUMAN SERVICES
the Association of Community Organizations for Reform Now (ACORN), or any of its affiliates,
subsidiaries, allied organizations, or successors.
SEC. 527. Prohibits Federal Funding for Needle Exchange Except in Limited
Circumstances. Notwithstanding any other provision of this Act, no funds appropriated in this
Act shall be used to purchase sterile needles or syringes for the hypodermic injection of any
illegal drug: Provided, That such limitation does not apply to the use of funds for elements of a
program other than making such purchases if the relevant State or local health depatttnent, in
consultation with the Centers for Disease Control and Prevention, determines that the State or
local jurisdiction, as applicable, is experiencing, or is at risk for, a significant increase in
hepatitis infections or an HIV outbreak due to injection drug use, and such program is operating
in accordance with State and local law.
Government -wide General Provisions
SEC. 718. Propaganda. No part of any appropriation contained in this or any other Act shall be
used directly or indirectly, including by private contractor, for publicity or propaganda purposes
within the United States not heretofore authorized by the Congress.
SEC. 732. Privacy Act. None of the funds made available in this Act may be used in
contravention of section 552a of title 5, United States Code (popularly known as the Privacy
Act), and regulations implementing that section.
SEC. 742. Confidentiality Agreements.
(a) None of the funds appropriated or otherwise made available by this or any other Act may be
available for a contract, grant, or cooperative agreement with an entity that requires employees or
contractors of such entity seeking to report fraud, waste, or abuse to sign internal confidentiality
agreements or statements prohibiting or otherwise restricting such employees or contactors from
lawfully reporting such waste, fraud, or abuse to a designated investigative or law enforcement
representative of a Federal department or agency authorized to receive such information.
(b) The limitation in subsection (a) shall not contravene requirements applicable to Standard
Form 312, Form 4414, or any other form issued by a Federal department or agency governing
the nondisclosure of classified information.
SEC. 743. Nondisclosure Agreements
(a) No funds appropriated in this or any other Act may be used to implement or enforce the
agreements in Standard Forms 312 and 4414 of the Government or any other nondisclosure
policy, form, or agreement if such policy, form, or agreement does not contain the following
provisions: "These provisions are consistent with and do not supersede, conflict with, or
x DEPARTMENT OF HEALTH & HUMAN SERVICES
otherwise alter the employee obligations, rights, or liabilities created by existing statute or
Executive order relating to (1) classified information, (2) communications to Congress, (3) the
reporting to an Inspector General of a violation of any law, rule, or regulation, or
mismanagement, a gross waste of funds, an abuse of authority, or a substantial and specific
danger to public health or safety, or (4) any other whistleblower protection. The definitions,
requirements, obligations, rights, sanctions, and liabilities created by controlling Executive
orders and statutory provisions are incorporated into this SEC. 743. (a) No funds appropriated in
this or any other Act may be used to implement or enforce the agreements in Standard Forms
312 and 4414 of the Government or any other nondisclosure policy, form, or agreement if such
policy, form, or agreement does not contain the following provisions: "These provisions are
consistent with and do not supersede, conflict with, or otherwise alter the employee obligations,
rights, or liabilities created by existing statute or Executive order relating to (1) classified
information, (2) communications to Congress, (3) the reporting to an Inspector General of a
violation of any law, rule, or regulation, or mismanagement, a gross waste of funds, an abuse of
authority, or a substantial and specific danger to public health or safety, or (4) any other
whistleblower protection. The definitions, requirements, obligations, rights, sanctions, and
liabilities created by controlling Executive orders and statutory provisions are incorporated into
this agreement and are controlling.": Provided, That notwithstanding the preceding provision of
this section, a nondisclosure policy form or agreement that is to be executed by a person
connected with the conduct of an intelligence or intelligence -related activity, other than an
employee or officer of the United States Government, may contain provisions appropriate to the
particular activity for which such document is to be used. Such form or agreement shall, at a
minimum, require that the person will not disclose any classified information received in the
course of such activity unless specifically authorized to do so by the United States Government.
Such nondisclosure forms shall also make it clear that they do not bar disclosures to Congress, or
to an authorized official of an executive agency or the Department of Justice, that are essential to
reporting a substantial violation of law.
(b) A nondisclosure agreement may continue to be implemented and enforced notwithstanding
subsection (a) if it complies with the requirements for such agreement that were in effect when
the agreement was entered into.
(c) No funds appropriated in this or any other Act may be used to implement or enforce any
agreement entered into during fiscal year 2014 which does not contain substantially similar
language to that required in subsection (a).
SEC. 744. Unpaid Federal Tax Liability. None of the funds made available by this or any other
Act may be used to enter into a contract, memorandum of understanding, or cooperative
agreement with, make a grant to, or provide a loan or loan guarantee to, any corporation that has
er DEPARTMENT OF HEALTH & HUMAN SERVICES
any unpaid Federal tax liability that has been assessed, for which all judicial and administrative
remedies have been exhausted or have lapsed, and that is not being paid in a timely manner
pursuant to an agreement with the authority responsible for collecting the tax liability, where the
awarding agency is aware of the unpaid tax liability, unless a Federal agency has considered
suspension or debarment of the corporation and has made a determination that this further action
is not necessary to protect the interests of the Government.
SEC. 745. Criminal Felony Limitation. None of the funds made available by this or any other
Act may be used to enter into a contract, memorandum of understanding, or cooperative
agreement with, make a grant to, or provide a loan or loan guarantee to, any corporation that was
convicted of a felony criminal violation under any Federal law within the preceding 24 months,
where the awarding agency is aware of the conviction, unless a Federal agency has considered
suspension or debarment of the corporation and has made a determination that this further action
is not necessary to protect the interests of the Government.
Other Appropriations Provisions
42 U.S.C. 289d note No funds appropriated under this Act or subsequent Departments of Labor,
Health and Human Services, and Education, and Related Agencies Appropriations Acts shall be
used by the National Institutes of Health, or any other Federal agency, or recipient of Federal
funds on any project that entails the capture or procurement of chimpanzees obtained from the
wild. For purposes of this section, the term `recipient of Federal funds' includes private citizens,
corporations, or other research institutions located outside of the United States that are recipients
of Federal funds.
Other Statutory Provisions
Trafficking in Persons
This award is subject to the requirements of Section 106 (g) of the Trafficking Victims
Protection Act of 2000, as amended (22 U.S.C. 7104)
a. Provisions applicable to a recipient that is a private entity.
1. You as the recipient, your employees, subrecipients under this award, and subrecipients'
employees may not
i. Engage in severe forms of trafficking in persons during the period of time that the award
is in effect;
ii. Procure a commercial sex act during the period of time that the award is in effect; or
iii. Use forced labor in the performance of the award or subawards under the award.
2. We as the Federal awarding agency may unilaterally terminate this award, without penalty, if
you or a subrecipient that is a private entity —
i. Is determined to have violated a prohibition in paragraph a.1 of this award term; or
DEPARTMENT OF HEALTH & HUMAN SERVICES
ii. Has an employee who is determined by the agency official authorized to terminate the award
to have violated a prohibition in paragraph a.1 of this award term through conduct that is either -
A. Associated with performance under this award; or
B. Imputed to you or the subrecipient using the standards and due process for imputing the
conduct of an individual to an organization that are provided in 2 CFR part 180, "OMB
Guidelines to Agencies on Governmentwide Debarment and Suspension (Nonprocurement)," as
implemented by our agency at 2 CFR part 376.
b. Provision applicable to a recipient other than a private entity.
We as the Federal awarding agency may unilaterally terminate this award, without penalty, if a
subrecipient that is a private entity-
1. Is determined to have violated an applicable prohibition in paragraph a.1 of this award term; or
2. Has an employee who is determined by the agency official authorized to terminate the award
to have violated an applicable prohibition in paragraph a.1 of this award term through conduct
that is either
i. Associated with performance under this award; or
ii. Imputed to the subrecipient using the standards and due process for imputing the conduct of
an individual to an organization that are provided in 2 CFR part 180, "OMB Guidelines to
Agencies on Governmentwide Debarment and Suspension (Nonprocurement)," as implemented
by our agency at 2 CFR part 376
c. Provisions applicable to any recipient.
1. You must inform us immediately of any information you receive from any source alleging a
violation of a prohibition in paragraph a.1 of this award term
2. Our right to terminate unilaterally that is described in paragraph a.2 or b of this section:
i. Implements section 106(g) of the Trafficking Victims Protection Act of 2000 (TVPA), as
amended
(22 U.S.C. 7104(g)), and
ii. Is in addition to all other remedies for noncompliance that are available to us under this award.
3. You must include the requirements of paragraph a.1 of this award term in any subaward you
make
to a private entity.
d. Definitions. For purposes of this award term:
1. "Employee" means either:
i. An individual employed by you or a subrecipient who is engaged in the performance of the
project or program under this award; or
ii. Another person engaged in the performance of the project or program under this award and
not compensated by you including, but not limited to, a volunteer or individual whose services
are contributed by a third party as an in -kind contribution toward cost sharing or matching
requirements.
2. "Forced labor" means labor obtained by any of the following methods: the recruitment,
harboring, transportation, provision, or obtaining of a person for labor or services, through the
x DEPARTMENT OF HEALTH & HUMAN SERVICES
it1�`daan
use of force, fraud, or coercion for the purpose of subjection to involuntary servitude, peonage,
debt bondage, or slavery.
3. "Private entity":
i. Means any entity other than a State, local government, Indian tribe, or foreign public entity, as
those terms are defined in 2 CFR 175.25.
ii. Includes:
A. A nonprofit organization, including any nonprofit institution of higher education, hospital, or
tribal organization other than one included in the definition of Indian tribe at 2 CFR 175.25(b).
B A for -profit organization.
4. "Severe forms of trafficking in persons," "commercial sex act," and "coercion" have the
meanings given at section 103 of the TVPA, as amended (22 U.S.C. 7102)
Whistleblower Protections
You are hereby given notice that the 48 CFR section 3.908, implementing section 828, entitled
"Pilot
Program for Enhancement of Contractor Employee Whistleblower protections," of the National
Defense Authorization Act (NDAA) for Fiscal Year (FY) 2013 (Pub. L. 112-239, enacted
January 2,
2013) applies to this award.
Human Subjects Protections
If any activities under this project will involve human subjects in any research activities, you
must provide satisfactory assurance of compliance with the participant protection requirement of
the HHS/OASH Office of Human Research Protection (OHRP) prior to implementation of those
research components. This assurance should be submitted to the OHRP in accordance with the
appropriate regulations.
Fraud, Abuse and Waste:
The HHS Inspector General accepts tips and complaints from all sources about potential fraud,
waste, abuse, and mismanagement in Department of Health and Human Services' programs.
Your information will be reviewed promptly by a professional staff member. Due to the high
volume of information that they receive, they are unable to reply to submissions. You may reach
the OIG through various channels.
Internet: https://forms.oig.hhs.gov/hotlineoperations/index.aspx
Phone: 1-800-HHS-TIPS (1-800-447-8477)
Mail: US Department of Health and Human Services
Office of Inspector General
ATTN: OIG HOTLINE OPERATIONS
PO Box 23489
Washington, DC 20026
For additional information visit https://oig.hhs.gov/fraud/report-fraud/index.asp
WELLS
FARO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office®
Treasury Information Reporting
Currency: USD
Bank: 121000248
Account: 2696204833948(FL)
WELLS FARGO BANK, N.A.
CITY OF MIAMI
Payment Amount:
Originator
156,856.74
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Payment Detail
CCD
US HHS Stimulus
1911911912
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
HHSPAYMENT
City Of Miami
596000375
Addenda Items:
Trace:
Settlement Date:
Effective Date:
Addenda Detail
0
124384872311039
04/17/2020
04/17/2020
Remittance (BPR)
Transaction Type:
Payment Amount:
Credit/Debit:
Method:
Format:
Originator ID Type:
Originator ID:
Originator Company ID:
Receiver ID Type:
Receiver ID:
Receiver Account Type:
Receiver Account Number:
Effective Date:
Note/Special Instruction (NTE)
PAYMT ACCOMP. REMIT
156,856.74
C
ACH
CCP
ABA T/R
124384877
1911911912
ABA T/R
121000248
DEMAND DEPOSIT
2696204833948
20200417
Description:
Description:
Note Reference Type:
Description:
Note Reference Type:
Description:
Reference ID (REF)
PAYMENT ADDENDA FORMAT ERROR
TOO MANY ELMENTS IN SEGMENT.
PAYMENT
TRN 1 750226564 1911911912 CARES ACT RELIEF PAYMENT HHS.GOV
PAYMENT
PH 866-569-3522
Reference ID Type:
Reference ID:
Date/Time Reference (DTM)
TRACE NUMBER
124384872311039
Date Description:
Date:
Name (NI)
SETTLE DATE/ORIGINAT
20200417
Entity ID Type:
Name:
ID Type:
ID:
Entity ID Type:
Name:
PAYEE
City Of Miami
ID CODE
596000375
PAYER
US HHS Stimulus
Page: 1
Note: Intraday information subject to change
WELLS
FARGO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office®
Treasury Information Reporting
Payment Amount:
Originator
73,670.38
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Discretionary Data:
Payment Detail
CCD
ELAVON MER SVCS
9990100039
MERCHANT ACTIVITY
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
MERCH DEP
CITY OF
MIAM0000000000
8030254604
Addenda Items:
Trace:
Settlement Date:
Effective Date:
Addenda Detail
0
091000014794408
04/17/2020
04/17/2020
Remittance (BPR)
Transaction Type:
Payment Amount:
Credit/Debit:
Method:
Format:
Originator ID Type:
Originator ID:
Originator Company ID:
Receiver ID Type:
Receiver ID:
Receiver Account Type:
Receiver Account Number:
Effective Date:
Trace Number (TRN)
PAYMT ACCOMP. REMIT
73,670.38
C
ACH
CCD
ABA T/R
091000019
9990100039
ABA T/R
121000248
DEMAND DEPOSIT
2696204833948
20200417
Type: CURRENT TRAN TRACE #
Trace: 091000014794408
Date/Time Reference (DTM)
Date Description:
Date:
Date Description:
Date:
Name (N1)
SETTLE DATE/ORIGINAT
20200417
EFFECTIVE
20200417
Entity ID Type:
Name:
ID Type:
ID:
Entity ID Type:
Name:
PAYEE
CITY OF MIAM0000000000
ID CODE
8030254604
PAYER
ELAVON MER SVCS
Payment Amount:
Originator
18,484.97
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Discretionary Data:
Payment Detail
CCD
ELAVON MER SVCS
9990100039
MERCHANT ACTIVITY
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
MERCH DEP
MIA
CHANGEHE0000000000
8033275911
Addenda Items:
Trace:
Settlement Date:
Effective Date:
0
091000014794365
04/17/2020
04/17/2020
Page: 2
Note: Intraday information subject to change
WELLS
FARGO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office®
Treasury Information Reporting
Addenda Detail
Remittance (BPR)
Transaction Type:
Payment Amount:
Credit/Debit:
Method:
Format:
Originator ID Type:
Originator ID:
Originator Company ID:
Receiver ID Type:
Receiver ID:
Receiver Account Type:
Receiver Account Number:
Effective Date:
Trace Number (TRN)
PAYMT ACCOMP. REMIT
18,484.97
C
ACH
CCD
ABA T/R
091000019
9990100039
ABA T/R
121000248
DEMAND DEPOSIT
2696204833948
20200417
Type:
Trace:
Date/Time Reference (DTM)
CURRENT TRAN TRACE #
091000014794365
Date Description:
Date:
Date Description:
Date:
Name (N1)
SETTLE DATE/ORIGINAT
20200417
EFFECTIVE
20200417
Entity ID Type:
Name:
ID Type:
ID:
Entity ID Type:
Name:
PAYEE
MIA CHANGEHE0000000000
ID CODE
8033275911
PAYER
ELAVON MER SVCS
Payment Amount:
Originator
9,187.00
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Discretionary Data:
Payment Detail
CTX
MIAMI-DADE COUNT
1269620669
ACH TRANSFER
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
VENDOR PAY
OF MIAMI
596000375 03
Addenda Items:
Trace:
Settlement Date:
Effective Date:
6
091000016723551
04/17/2020
04/17/2020
Payment Amount:
Originator
3,443.55
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Discretionary Data:
Payment Detail
CCD
ELAVON MER SVCS
9990100039
MERCHANT ACTIVITY
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
MERCH DEP
MIA MARINA
A0000001005
385100300000725
Addenda Items:
Trace:
Settlement Date:
Effective Date:
0
091000014794186
04/17/2020
04/17/2020
Page: 3
Note: Intraday information subject to change
WELLS
FARGO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office® Treasury Information Reporting
Addenda Detail
Remittance (BPR)
Transaction Type: PAYMT ACCOMP. REMIT
Payment Amount: 3,443.55
Credit/Debit: C
Method: ACH
Format: CCD
Originator ID Type: ABA T/R
Originator ID: 091000019
Originator Company ID: 9990100039
Receiver ID Type: ABA T/R
Receiver ID: 121000248
Receiver Account Type: DEMAND DEPOSIT
Receiver Account Number: 2696204833948
Effective Date: 20200417
Trace Number (TRN)
Type:
Trace:
Date/Time Reference (DTM)
CURRENT TRAN TRACE #
091000014794186
Date Description: SETTLE DATE/ORIGINAT
Date: 20200417
Date Description: EFFECTIVE
Date: 20200417
Name (N1)
Entity ID Type: PAYEE
Name: MIA MARINA A0000001005
ID Type: ID CODE
ID: 385100300000725
Entity ID Type: PAYER
Name: ELAVON MER SVCS
Payment Amount:
Originator
2,917.17
Receiver
Entry Class: PPD Transaction Type: Credit
Originator Company Name: FCSO, INC. Entry Description: HCCLAIMPMT
Originator Company ID: 6593514335 Receiver Name: CITY OF MIAMI
Discretionary Data: FIRST COAST SVC OPT Receiver ID: 1821109612
Payment Detail
Addenda Items: 0
Trace: 031100203046660
Settlement Date: 04/17/2020
Effective Date: 04/17/2020
Addenda Detail
Remittance (BPR)
Transaction Type: PAYMT ACCOMP. REMIT
Payment Amount: 2,917.17
Credit/Debit: C
Method: ACH
Format: PPP
Originator ID Type: ABA T/R
Originator ID: 031100209
Originator Company ID: 6593514335
Receiver ID Type: ABA T/R
Receiver ID: 121000248
Receiver Account Type: DEMAND DEPOSIT
Receiver Account Number: 2696204833948
Effective Date: 20200417
Page: 4
Note: Intraday information subject to change
WELLS
FARGO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office® Treasury Information Reporting
Trace Number (TRN)
Type: CURRENT TRAN TRACE #
Trace: 806235186
Company ID: 1593514335
Reference ID (REF)
Reference ID Type: TRACE NUMBER
Reference ID: 031100203046660
Date/Time Reference (DTM)
Date Description: SETTLE DATE/ORIGINAT
Date: 20200417
Name (NI)
Entity ID Type: PAYEE
Name: CITY OF MIAMI
ID Type: ID CODE
ID: 1821109612
Entity ID Type: PAYER
Name: FCSO, INC.
Payment Amount:
Originator
665.00
Receiver
Entry Class: CTX Transaction Type: Credit
Originator Company Name: STATE OF FLORIDA Entry Description: PAYMENTS
Originator Company ID: 9001395052 Receiver Name: CITY OF MIAMI
Receiver ID: 152898180581458
Payment Detail
Addenda Items: 7
Trace: 091000014003889
Settlement Date: 04/17/2020
Effective Date: 04/17/2020
Addenda Detail
Remittance (BPR)
Transaction Type: PAYMENT ACCOMP REMIT
Payment Amount: 665.00
Credit/Debit: C
Method: ACH
Format: CTX
Originator ID Type: ABA T/R
Originator ID: 091000019
Originator Account Type: DEMAND DEPOSIT
Originator Account Number: 2079900545225
Originator Company ID: 9001395052
Receiver ID Type: ABA T/R
Receiver ID: 121000248
Receiver Account Type: DEMAND DEPOSIT
Receiver Account Number: 2696204833948
Effective Date: 20200417
Trace Number (TRN)
Type:
Trace:
Reference ID (REF)
CURRENT TRAN TRACE #
152898180581458
Reference ID Type:
Reference ID:
Reference Description:
Date/Time Reference (DTM)
TRACE NUMBER
091000014003889
ACH ASSIGNED TRACE NUMBER
Date Description: SETTLE DATE/ORIGINAT
Date: 20200417
Page: 5
Note: Intraday information subject to change
WELLS
FARO
Name (NI)
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office®
Treasury Information Reporting
Entity ID Type:
Name:
Entity ID Type:
Name:
Communications Contact (PER)
PAYEE
CITY OF MIAMI
PAYER
STATE OF FLORIDA
Contact Function Type:
Name:
Contact Number Type:
Contact Number:
ACCOUNTING DEPARTMEN
DEPT. OF HIGHWAY SAFETY & MOTOR VEH
TEL.
(850) 617-3301
Accounts Receivable Open Item Reference (RMR)
Reference ID Type:
Reference ID:
Payment Action Type:
Amount Paid:
SELLER'S INVC NBR
EC041320
PAYMENT ON ACCOUNT
665.00
Payment Amount:
Originator
615.91
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Payment Detail
CCD
CIGNA
9751677627
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
HCCLAIMPMT
/CITY OF MIAMI EMERG
S
1821109612
Addenda Items:
Trace:
Settlement Date:
Effective Date:
Addenda Detail
0
091000012203010
04/17/2020
04/17/2020
Remittance (BPR)
Transaction Type:
Payment Amount:
Credit/Debit:
Method:
Format:
Originator ID Type:
Originator ID:
Originator Company ID:
Receiver ID Type:
Receiver ID:
Receiver Account Type:
Receiver Account Number:
Effective Date:
Trace Number (TRN)
PAYMT ACCOMP. REMIT
615.91
C
ACH
CCP
ABA T/R
091000019
9751677627
ABA T/R
121000248
DEMAND DEPOSIT
2696204833948
20200417
Type:
Trace:
Company ID:
Reference ID (REF)
CURRENT TRAN TRACE #
200414090026852
1591031071
Reference ID Type: TRACE NUMBER
Reference ID:
Date/Time Reference (DTM)
091000012203010
Date Description: SETTLE DATE/ORIGINAT
Date:
20200417
Page: 6
Note: Intraday information subject to change
WELLS
FARO
Name (N1)
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office®
Treasury Information Reporting
Entity ID Type:
Name:
ID Type:
ID:
Entity ID Type:
Name:
PAYEE
/CITY OF MIAMI EMERG S
ID CODE
1821109612
PAYER
CIGNA
Payment Amount:
Originator
404.46
Receiver
Entry Class:
Originator Company Name:
Originator Company ID:
Discretionary Data:
Payment Detail
CCD
AMERICAN EXPRESS
1134992250
PAYMENT DATE 20108
Transaction Type:
Entry Description:
Receiver Name:
Receiver ID:
Credit
SETTLEMENT
MARINE
STADI1090175548
1090175548
Addenda Items:
Trace:
Settlement Date:
Effective Date:
Addenda Detail
0
091000016032705
04/17/2020
04/17/2020
Remittance (BPR)
Transaction Type:
Payment Amount:
Credit/Debit:
Method:
Format:
Originator ID Type:
Originator ID:
Originator Company ID:
Receiver ID Type:
Receiver ID:
Receiver Account Type:
Receiver Account Number:
Effective Date:
Trace Number (TRN)
PAYMT ACCOMP. REMIT
404.46
C
ACH
CCD
ABA T/R
091000019
1134992250
ABA T/R
121000248
DEMAND DEPOSIT
2696204833948
20200417
Type:
Trace:
Date/Time Reference (DTM)
CURRENT TRAN TRACE #
091000016032705
Date Description:
Date:
Date Description:
Date:
Name (N1)
SETTLE DATE/ORIGINAT
20200417
EFFECTIVE
20200417
Entity ID Type:
Name:
ID Type:
ID:
Entity ID Type:
Name:
PAYEE
MARINE STADI1090175548
ID CODE
1090175548
PAYER
AMERICAN EXPRESS
Page: 7
Note: Intraday information subject to change
WELLS
FARGO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office® Treasury Information Reporting
Payment Amount:
Originator
402.32
Receiver
Entry Class: CCD Transaction Type: Credit
Originator Company Name: MERCHANT SERVICE Entry Description: MERCH DEP
Originator Company ID: 1841010148 Receiver Name: CM DINNER KEY MARINA
0
Discretionary Data: MERCHANT ACTIVITY Receiver ID: 8016259916
Payment Detail
Addenda Items: 0
Trace: 042000019225154
Settlement Date: 04/17/2020
Effective Date: 04/17/2020
Addenda Detail
Remittance (BPR)
Transaction Type: PAYMT ACCOMP. REMIT
Payment Amount: 402.32
Credit/Debit: C
Method: ACH
Format: CCD
Originator ID Type: ABA T/R
Originator ID: 042000013
Originator Company ID: 1841010148
Receiver ID Type: ABA T/R
Receiver ID: 121000248
Receiver Account Type: DEMAND DEPOSIT
Receiver Account Number: 2696204833948
Effective Date: 20200417
Trace Number (TRN)
Type:
Trace:
Date/Time Reference (DTM)
CURRENT TRAN TRACE #
042000019225154
Date Description: SETTLE DATE/ORIGINAT
Date: 20200417
Date Description: EFFECTIVE
Date: 20200417
Name (N1)
Entity ID Type: PAYEE
Name: CM DINNER KEY MARINA 0
ID Type: ID CODE
ID: 8016259916
Entity ID Type: PAYER
Name: MERCHANT SERVICE
Payment Amount:
Originator
289.71
Receiver
Entry Class: CCD Transaction Type: Credit
Originator Company Name: WEX BANK Entry Description: AP PAYMENT
Originator Company ID: 1010526993 Receiver Name: CITY OF MIAMI
Discretionary Data: 06192169 MERCH Receiver ID: MERC-AHT635514
Payment Detail
Addenda Items: 0
Trace: 041001038455870
Settlement Date: 04/17/2020
Effective Date: 04/17/2020
Page: 8
Note: Intraday information subject to change
WELLS
FARGO
EDI Payment Detail Report
Custom
As of 04/17/2020
Company: CITY OF MIAMI
User: Elmita Bolivar
04/20/2020 11:11 AM ET
Commercial Electronic Office® Treasury Information Reporting
Addenda Detail
Remittance (BPR)
Transaction Type: PAYMT ACCOMP. REMIT
Payment Amount: 289.71
Credit/Debit: C
Method: ACH
Format: CCD
Originator ID Type: ABA T/R
Originator ID: 041001039
Originator Company ID: 1010526993
Receiver ID Type: ABA T/R
Receiver ID: 121000248
Receiver Account Type: DEMAND DEPOSIT
Receiver Account Number: 2696204833948
Effective Date: 20200417
Trace Number (TRN)
Type:
Trace:
Date/Time Reference (DTM)
CURRENT TRAN TRACE #
041001038455870
Date Description: SETTLE DATE/ORIGINAT
Date: 20200417
Date Description: EFFECTIVE
Date: 20200417
Name (N1)
Entity ID Type: PAYEE
Name: CITY OF MIAMI
ID Type: ID CODE
ID: MERC-AHT635514
Entity ID Type: PAYER
Name: WEX BANK
Credit Total For Account 2696204833948(USD) 266,937.21
Account Net Total(USD) 266,937.21
Credit Total For Bank 121000248(USD) 266,937.21
Bank Net Total(USD) 266,937.21
Currency Credit Total(USD) 266,937.21
Currency Net Total(USD) 266,937.21
---- END OF REPORT ----
Page: 9
Note: Intraday information subject to change
Visit coronavirus.gov for the latest Coronavirus Disease (COVID-1 9) updates.
Read the 30 Days to Slow the Spread Guidance - PDF (version en Espanol - PDF).
HHS.gov
FOR IMMEDIATE RELEASE
April 10, 2020
U.S. Department of Health & Human Services
Contact: HHS Press Office
202-690-6343
media@hhs.gov
HHS to Begin Immediate Delivery of Initial $30 Billion of CARES Act
Provider Relief Funding
Today, the Department of Health and Human Services (HHS) is beginning the delivery of the initial $30
billion in relief funding to providers in support of the national response to COVID-19 as part of the
distribution of the $100 billion provider relief fund provided for in the Coronavirus Aid, Relief, and
Economic Security (CARES) Act recently passed by Congress and signed by President Trump.
The $100 billion of funding will be used to support healthcare -related expenses or lost revenue attributable
to coronavirus and to ensure uninsured Americans can get the testing and treatment they need without
receiving a surprise bill from a provider. The initial $30 billion in immediate relief funds will begin being
delivered to providers today.
Recognizing the importance of delivering the provider relief funds in a fast, fair, and transparent manner,
this initial broad -based distribution of the relief funds will go to hospitals and providers across the United
States that are enrolled in Medicare. Facilities and providers are allotted a portion of the $30 billion based
on their share of 2019 Medicare fee -for -service (FFS) reimbursements. These are payments, not loans, to
healthcare providers, and will not need to be repaid.
HHS and the Administration are working rapidly on additional targeted distributions to providers that will
focus on providers in areas particularly impacted by the COVID-19 outbreak, rural providers, and
providers of services with lower shares of Medicare FFS reimbursement or who predominantly serve the
Medicaid population. This supplemental funding will also be used to reimburse providers for COVID-19
care for uninsured Americans.
HHS is partnering with UnitedHealth Group (UHG) to deliver the initial $30 billion distribution to providers
as quickly as possible. Providers will be paid via Automated Clearing House account information on file
with UHG, UnitedHealthcare, or Optum Bank, or used for reimbursements from the Centers for Medicare
& Medicaid Services (CMS). Providers who normally receive a paper check for reimbursement from CMS
will receive a paper check in the mail for this payment as well, within the next few weeks.
Within 30 days of receiving the payment, providers must sign an attestation confirming receipt of the funds
and agreeing to the terms and conditions of payment. The portal for signing the attestation will be open
the week of April 13, 2020 and will be linked from hhs.gov/providerrelief.
UnitedHealth Group will donate all fees for the administration of the CARES Act provider relief fund.
Visit hhs.gov/providerrelief for additional information.
###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook § follow HHS on Twitter @HHSgov 7, and sign up for HHS Email Updates.
Last revised: April 10, 2020
4/29/2020 CARES Act Provider Relief Fund 1 HHS.gov
Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.
Read the 30 Days to Slow the Spread Guidance - PDF (version en Espanol - PDF).
HHS.gov
Coronavirus
U.S. Department of Health & Human Services
CARES Act Provider Relief Fund
Update: HHS has begun distributing the remaining $20 billion of the $50 billion general distribution to
Medicare providers to augment providers' allocations so that the whole $50 billion general distribution
is allocated proportional to providers' share of net patient revenue. Medicare providers for whom HHS
did not have adequate cost report data on file will need to submit their revenue information to
the General Distribution Portal to be able to receive additional general distribution funds and agree
to the Terms and Conditions for this additional distribution. Providers who received their additional
money automatically will still need to submit their revenue information so that it can be verified via the
portal. Click here for FAQs on the General Distribution Portal - PDF.
The COVID-19 Uninsured Program Portal, which allows healthcare providers who have
conducted COVID-19 testing or provided treatment for uninsured COVID-19 individuals on or after
February 4, 2020 to request claims reimbursement, is now live. Providers can access the portal to
register for the program at COVIDUninsuredClaim.HRSA.gov.
The CARES Act Provider Relief Fund Payment Attestation Portal is open. Providers who have been
allocated a payment must sign an attestation confirming receipt of the funds and agree to the terms
and conditions within 30 days of payment.
President Trump is providing support to healthcare providers fighting the COVID-19 pandemic. On March
27, 2020, the President signed the bipartisan CARES Act that provides $100 billion in relief funds to
hospitals and other healthcare providers on the front lines of the coronavirus response. This funding will
be used to support healthcare -related expenses or lost revenue attributable to COVID-19 and to ensure
uninsured Americans can get testing and treatment for COVID-19.
In allocating the funds, the Administration is working to address both the economic harm across the entire
healthcare system due to the stoppage of elective procedures, and addressing the economic impact on
providers incurring additional expenses caring for COVID-19 patients, and to do so as quickly and
transparently as possible.
$50 billion general allocation
https://www.hhs.gov/coronavirus/cares-act-provider-relief-fund/index.html 1 /4
4/29/2020 CARES Act Provider Relief Fund 1 HHS.gov
$50 billion of the Provider Relief Fund is allocated for general distribution to Medicare facilities and
providers impacted by COVID-19, based on eligible providers' net patient revenue. The initial $30 billion
was distributed between April 10 and April 17, and the remaining $20 billion is being distributed beginning
Friday, April 24.
• To expedite providers getting money as quickly as possible, $30 billion was distributed immediately,
proportionate to providers' share of Medicare fee -for -service reimbursements in 2019. On Friday,
April 10, $26 billion was delivered to bank accounts. The remaining $4 billion of the expedited $30
billion distribution was sent on April 17.
• This simple formula used the data on -hand to get the money out the door as quickly as possible. The
Administration was transparent and upfront additional funds would be going out quickly to help
providers with a relatively small share of their revenue coming from Medicare fee -for -service, such as
children's hospitals.
• HHS will begin distribution of the remaining $20 billion of the general distribution to these providers
on April 24 to augment their allocation so that the whole $50 billion general distribution is allocated
proportional to providers' share of net patient revenue.
• On April 24, a portion of providers will automatically be sent an advance payment based off the
revenue data they submit in CMS cost reports. Providers without adequate cost report data on file
will need to submit their revenue information to the General Distribution Portal for additional general
distribution funds.
- Providers who receive their money automatically will still need to submit their revenue information
so that it can be verifiedvia the General Distribution Portal
• Payments will go out weekly, on a rolling basis, as information is validated, with the first wave being
delivered at the end of this week (April 24, 2020).
• Providers who receive funds from the general distribution have to sign an attestation confirming
receipt of funds and agree to the terms and conditions of payment and confirm the CMS cost report.
Click here to sign the attestation and accept the Terms and Conditions
• The Terms and Conditions also include other measures to help prevent fraud and misuse of the
funds. All recipients will be required to submit documents sufficient to ensure that these funds were
used for healthcare -related expenses or lost revenue attributable to coronavirus. There will be
significant anti -fraud and auditing work done by HHS, including the work of the Office of the Inspector
General.
• President Trump is committed to ending surprise bills for patients. As part of this commitment, as a
condition to receiving these funds, providers must agree not to seek collection of out-of-pocket
https://www.hhs.gov/coronavirus/cares-act-provider-relief-fund/index.html 2/4
4/29/2020 CARES Act Provider Relief Fund I HHS.gov
payments from a presumptive or actual COVID-19 patient that are greater than what the patient
would have otherwise been required to pay if the care had been provided by an in -network provider.
Targeted allocations
Allocation for treatment of the uninsured
Allocation for COVID-19 high impact areas ($10 billion)
Allocation for rural providers ($10 billion)
Allocation for Indian Health Service ($400 million)
Additional allocations
Helping ensure all Americans have access to care
• The Families First Coronavirus Response Act, as amended by the CARES Act, requires private
insurers to waive an insurance plan member's cost -sharing payments for COVID-19 testing. The
President also secured funding to cover COVID-19 testing for uninsured Americans.
• President Trump has also secured commitments from private insurers, including Humana, Cigna,
UnitedHealth Group, and the Blue Cross Blue Shield system, to waive cost -sharing payments for
treatment related to COVID-19 for plan members.
• Additionally, President Trump is committed to ending surprise bills for patients. As part of this
commitment, as a condition to receiving general funds, providers must agree not to seek collection
of out-of-pocket payments from a presumptive or actual COVID-19 patient that are greater than
what the patient would have otherwise been required to pay if the care had been provided by an
in -network provider.
Additional information on the initial $30 billion distribution
Recognizing the importance of delivering funds in a fast and transparent manner, $30 billion is being
distributed immediately — with payments arriving via direct deposit beginning April 10, 2020 — to eligible
providers throughout the American healthcare system. These are payments, not loans, to healthcare
providers, and will not need to be repaid.
Read the a state -by -state breakdown of the initial $30 billion general distribution - PDF. Note that this
breakdown shows the amount allocated to billing organization for eligible recipients based on the billing
organizations' address, not necessarily the state where the providers are operating.
Who is eligible for initial $30 billion?
https://www.hhs.gov/coronavirus/cares-act-provider-relief-fund/index.html 3/4
4/29/2020 CARES Act Provider Relief Fund I HHS.gov
How are payment distributions determined?
What to do if you are an eligible provider?
Is this different than the CMS Accelerated and Advance Payment Program?
How does this apply to different types of providers?
Ensuring Americans are not surprised by bills for COVID-19 medical expenses
The Trump Administration is committed to ensuring that Americans are protected against financial
obstacles that might prevent them from getting the testing and treatment they need from COVID-19.
• As announced in early April, a portion of the $100 billion Provider Relief Fund will be used to
reimburse healthcare providers, at Medicare rates, for COVID-related treatment of the uninsured.
- As a condition, providers are obligated to abstain from "balance billing" any patient for COVID-
related treatment.
• The Families First Coronavirus Response Act requires private insurers to cover an insurance plan
member's cost -sharing payments for COVID-19 testing.
• President Trump has also secured commitments from private insurers, including Humana, Cigna,
UnitedHealth Group, and the Blue Cross Blue Shield system to waive cost -sharing payments for
treatment related to COVID-19 for plan members.
Content created by Assistant Secretary for Public Affairs (ASPA)
Content last reviewed on April 28, 2020
https://www.hhs.gov/coronavirus/cares-act-provider-relief-fund/index.html 4/4